ftInvstr
VIYASH · Healthcare ₹266.15 +1.97% Mkt Cap ₹11581 Cr overvalued
← Search another stock

VIYASH

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹266.15
+1.97% today · 30d -2.33%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for VIYASH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹946 Cr
+114.39% YoY
NET PROFIT
₹79 Cr
+351.28% YoY
OPM
19.56%
+6.97pp YoY
EPS
₹1.51
PE 55.39
Intrinsic value · DCF ₹64.92 · Margin of safety -75.6% (overvalued) · FCF yield 1.62%
◇ Sector Position
PEERPEROCE %
VIYASH55.3919.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 20
Growth STRONG 86
Profitability HIGH 78
Technicals NEUTRAL 52
Risk MODERATE 50
Key Stats
TTM PE
55.39
P/B
3.95
52W HIGH
₹298.0
OFF HIGH
-10.69%
MKT CAP
₹11581 Cr
◉ Active Signals
MACDBearish-0.4554
RSI(14)Neutral50.94
Street Consensus
4 analysts
₹322.25
mean target
Low ₹310.0Now ₹266.15High ₹334.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIYASH and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.